Gleamer vs Milvue (2026)
Two Paris fracture aids built on similar designs, and both publish how their models behave. Both return a solid box for a confident finding and a dotted box for a doubtful one at published operating points, both run on premises or in the cloud, and both publish results compared across age groups and anatomical regions in their FDA summaries. Gleamer's BoneView is cleared for adults across all regions and for children on the limbs, sits in a suite that now spans chest X-ray, CT, breast and MRI products, reports more than 60 million exams a year, and has been part of DeepHealth, RadNet's digital health subsidiary, since March 2026. Milvue is cleared for fractures from birth onward and pairs detection with about 60 automatic measurements and a pre filled report. If your failure mode is a broad imaging suite with a large US operator behind it, start with Gleamer. If it is detection, measurement and a drafted report in one radiograph tool, start with Milvue.
- Its FDA summary reports a 24 reader study in which aided sensitivity rose from 0.648 to 0.752 and specificity from 0.906 to 0.956, and describes a training set of 44,649 radiographs by sex and age.
- The suite reaches past radiographs, with ChestView and BoneMetrics FDA cleared and products for chest and bone CT, breast imaging and brain and lumbar spine MRI.
- Scale and ownership are substantial, with more than 60 million exams a year across more than 3,500 sites, and RadNet stating it intends to deploy the tools across its own network of more than 400 imaging centers.
- Detection and measurement come in one tool, with about 60 automatic bone measurements, including bone age, EOS and Cobb angles, and a pre filled report returned in under 30 seconds.
- Fracture detection is cleared from birth onward across 13 anatomical regions, with elbow effusions from age two.
- Its FDA summary publishes results by age band, sex and imaging manufacturer as well as region, with the lowest figures, at the adult pelvis and in children under two, visible.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Gleamer and Milvue are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Gleamer | Milvue |
|---|---|---|
| Primary category | Radiology & Imaging AI | Radiology & Imaging AI |
| Founded | 2017 | 2018 |
| Headquarters | Saint-Mandé, France | Paris, France |
| Website | gleamer.ai | milvue.com |
Side by Side
Select any grade to read the note behind it.
Product updates
The latest logged changes from each vendor, newest first, each linked to its source.
Milvue
-
Clinical evidence
A retrospective single-center study published in Diagnostics externally validated several CE-certified AI systems, including Milvue's TechCare Kids, for automated bone age assessment.
Source
Each vendor in one paragraph
Written to be quoted whole. Each paragraph opens the AI Health Index profile of the vendor: what the product is, who buys it and what it does.
Gleamer SAS is a radiology AI company based in Saint-Mandé, on the edge of Paris, and since 2 March 2026 part of DeepHealth, the digital health subsidiary of the US imaging services operator RadNet, Inc. RadNet announced the all cash acquisition at up to 230 million euros, about 215 million at closing plus a 15 million contingent milestone. Gleamer's site and products keep the Gleamer name.
Source: AI Health Index, July 2026
French imaging AI company based in Paris whose Milvue Suite reads plain radiographs. TechCare Alert detects fractures, dislocations, joint effusions, pneumothorax and nodules; TechCare Metrics returns about 60 automated bone measurements, including lower limbs, EOS, bone age and Cobb angles; and TechCare Report pre-fills the radiology report, which the company labels as not a medical device, with results returned in under 30 seconds.
Source: AI Health Index, July 2026
Questions buyers ask
How do Gleamer and Milvue work with the EHR?
Gleamer has been part of DeepHealth, the digital health subsidiary of RadNet, since March 2026, and nothing published says whether the products now run inside DeepHealth's platform or remain available on other vendors' archives.
Milvue is also listed in the Blackford Analysis imaging AI portfolio, a named orchestration platform that gives a second route into an existing workflow. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified July 22, 2026. No vendor pays for placement.
How are Gleamer and Milvue priced and sold?
In Gleamer's case, the packaging and the owner are public. The products are sold as modules of the Gleamer Copilot suite, and since March 2026 Gleamer has been part of DeepHealth, the digital health subsidiary of RadNet, so contracting may run through DeepHealth.
For Milvue, the module structure is public, though. TechCare Alert handles detection, TechCare Metrics handles measurements and TechCare Report produces the prefilled report, and the three carry different regulatory status. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified July 22, 2026. No vendor pays for placement.
How do Gleamer and Milvue handle patient data?
When Gleamer receives patient data from a customer, including imaging examinations and reports, it acts as the customer's processor and works on pseudonymized data, and where the customer authorizes it, Gleamer may anonymize pseudonymized patient data and use the anonymized result for its own purposes, including training and developing its products.
In Milvue's case, the TechCare Trauma 510(k) summary (K242171) states that the software is deployed on premises or in the cloud; a hospital that runs it on premises keeps its studies inside its own systems, which removes most of the retention and secondary use question for that site. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified July 22, 2026. No vendor pays for placement.
Which settings and specialties do Gleamer and Milvue cover?
For Gleamer, the suite now claims far wider coverage, described by the company as covering all imaging modalities, with products for chest X-ray, chest CT, bone CT, breast imaging, brain MRI and lumbar spine MRI. Validation for those is not summarized on the home page, and ChestView and BoneMetrics have their own FDA summaries.
With Milvue, the home page's "fracture detection validated with no age limit" matches the cleared indication from birth. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified July 22, 2026. No vendor pays for placement.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Decision Support page.
Neither vendor publishes a price, an information security attestation or business associate terms; both name ISO 13485, which covers the device quality system. Gleamer's privacy policy states that no data leaves the European Union, while Milvue's covers only its website, and neither names a cloud hosting region. Milvue's claim of an area under the curve above 96 percent across all ages is contradicted by its own summary's figures for infants and patients 65 and over.
An earlier version of this comparison said Milvue's headline figure is not broken out by pathology, region or age and that neither vendor publishes a demographic subgroup analysis; both FDA summaries publish results by age group, and Milvue's also by sex and manufacturer. Those statements were corrected on 10 October 2026.